Stock ALBPS BIOPHYTIS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Biophytis S.A.

Equities

ALBPS

FR001400OLP5

Market Closed - Euronext Paris
Other stock markets
 11:35:02 2024-06-19 am EDT 		5-day change 1st Jan Change
0.63 EUR -3.08% Intraday chart for Biophytis S.A. -3.82% -69.12%
Jun. 10 Biophytis Files Investigational New Drug Application with US FDA for Mid-stage Obesity Drug Trial MT
Jun. 10 Biophytis: application filed in obesity in the USA CF

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Biophytis S A : extends its contract with Atlas to secure financing for its business activities
PU
Biophytis S A : prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
PU
Biophytis S A : annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
PU
Biophytis S A : announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
PU
Biophytis S A : announces filing of an IND application with the US FDA for its phase 2 study in obesity
PU
Biophytis S A : annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité
PU
Biophytis S A : Assemblée générale mixte du 24 juin 2024
PU
Biophytis S A : Combined General Meeting of June 24, 2024
PU
Biophytis S A : annonce le design de son étude clinique de phase 2 OBA dans l'obésité
PU
Biophytis S A : announces the design of its phase 2 OBA clinical study in obesity
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALBPS Stock
  4. News Biophytis S.A.
  5. Press Releases